Early during the COVID-19 pandemic, it was recognized that infection with SARS-CoV-2 was associated with an increased risk of both arterial and venous thrombotic complications. This association is strongest for venous thromboembolic disease, but the risk of myocardial infarction (MI) is approximately doubled in the 7 days after COVID-19 diagnosis. Multiple studies have suggested worse outcomes in patients with COVID-19 and MI, with direct effects of the virus on endothelial cells, increased propensity for vascular thrombosis, and deficient care delivery all mechanistically implicated.
Source: JAMA Online First